The global CAR T-cell therapy market shows significant expansion in recent years. This trend is driven by the growing prevalence of cancer, advancements in therapy, and a surging demand for effective treatment options. The market is anticipated to arrive at a value of US\$XX billion by 20XX, with a compound annual growth rate (CAGR) of nearly XX%.